Skip to main content
William Stanford, MD, Internal Medicine, Sherman Oaks, CA, Cedars-Sinai Medical Center

WilliamPatrickStanfordMDPhD FACP(He/Him)

Internal Medicine Sherman Oaks, CA

Preventive Medicine, Complementary and Integrative Medicine

Chief Medical Officer

Dr. Stanford is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stanford's full profile

Already have an account?

Summary

  • I am a scientist at heart, having begun my career as a Mechanical and Aerospace Engineer at Texas Instruments in 1982. I became interested in biomedical science and began the combined MD/PhD program at UCLA in 1991. I completed medical school in 1998, PhD (Physiology) in 1999 and Internal Medicine residency in 2001, all at UCLA. Since that time, I have worked in Hospital Medicine, mostly as a clinician along with management and quality improvement positions, most of which were at Cedars-Sinai Medical Center in Los Angeles.

    Recent advances in Genomics and Precision Medicine have led me to complete Professional Certification in Genetics and Genomics through Stanford University in 2018. This training included coursework in next generation sequencing (NGS) of DNA and RNA, transcriptome analysis, pharmacogenomics, microbiomics, epigenetics, proteomics, gene editing and stem cell techniques. I recognize the significance of these technological developments empowered by incredible advances in basic science research, along with the development of powerful tools for sequencing and data analysis that leverages artificial intelligence. The current one-size-fits-all approach to healthcare does not seem to begin to leverage the incredible realities that the state of biomedical science finds itself in 2021. These advancements will enable prediction, prevention, treatment and cures for diseases by personalizing treatment based on each individual patient's genetic, biochemical and physiologic signature.

    Precision Medicine will ultimately deliver healthcare more efficiently and cost-effectively than current models, enabling us to deliver better healthcare to more people for less GDP. I will combine my extensive clinical experience and leadership, along with my strong scientific background and knowledge of Precision Medicine, to help lead the Internal Medicine community in bringing Precision Medicine to routine clinical practice.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1998 - 2001
  • UCLA School of Medicine
    UCLA School of MedicinePhD, 1999
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1998
  • University of Dallas, Graduate School of Engineering Management
    University of Dallas, Graduate School of Engineering ManagementNo Degree, 1983 - 1988
  • University of Missouri
    University of MissouriBS, Mechanical and Aerospace Engineering, Cum Laude, 1978 - 1982
  • University of Missouri
    University of MissouriBS, Mechanical Engineering, 1978 - 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • AOA UCLA School of Medicine, 1997
  • Fellow American College of Physicians, 2017
  • Friend of Nursing Award Cedars-Sinai Medical Center, 2016
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Atherosclerotic calcification: Relation to developmental osteogenesis  
    Bostrom K., Watson K.E., Stanford W.P., and Demer L.L., American Journal of Cardiology, 1/1/1995

Books/Book Chapters

Abstracts/Posters

  • Molecular and cellular regulation of vascular calcification: analogies with embryonic osteogenesis.
    Demer L.L., Watson K.E., Bostrom K., Stanford W.P., and Parhami F, Annual Meeting of the Association of University Cardiologists, Naples, FL, 1/1/1996
  • Human aortic endothelial cells produce bone morphogenetic protein-4 (BMP-4) and osteopontin, but not BMP-2.
    Stanford W.P., Parhami F., Morrow A., Schwartz D., Bostrom K., and Demer L.L., American Heart Association, Laverna Titus Young Investigators Symposium, Los Angeles, CA, 1/1/1995
  • Human aortic endothelial Cells express bone morphogenetic protein: possible implication of embryonal mechanism in arterial calcification.
    Stanford W.P., Parhami F., Bostrom K., and Demer L.L., Annual Meeting of Experimental Biology, Atlanta, GA, 1/1/1995
  • Join now to see all

Lectures

  • Improved Efficiency in Progression of Care Rounds by Integrating Hospitalists 
    Orlando, FL - 1/1/2015

Press Mentions

  • Listenmed Pays It Forward to People in Need in California
    Listenmed Pays It Forward to People in Need in CaliforniaJanuary 14th, 2021

Hospital Affiliations